. 2017 Feb 14;5(2):e00297. doi: 10.1002/prp2.297
© 2017 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Figure 5.
Serious ADRs reported for fluoroquinolones.